tiprankstipranks
Santhera Pharmaceuticals Holding (CH:SANN)
:SANN
Switzerland Market
SANN
Santhera Pharmaceuticals Holding
RESEARCH TOOLSreports

Santhera Pharmaceuticals Holding (SANN) Stock News & Sentiment

4 Followers
Santhera: Advancing AGAMREE Reimbursement and European Uptake Underpins Reiterated Buy and CHF30 Target
Premium
Ratings
Santhera: Advancing AGAMREE Reimbursement and European Uptake Underpins Reiterated Buy and CHF30 Target
2d ago
Santhera Pharmaceuticals Advances Vamorolone Study for Duchenne Muscular Dystrophy
Premium
Company Announcements
Santhera Pharmaceuticals Advances Vamorolone Study for Duchenne Muscular Dystrophy
5M ago
SPHDF
Santhera’s Earnings Call: Positive Outlook Amid Challenges
Premium
Company Announcements
Santhera’s Earnings Call: Positive Outlook Amid Challenges
6M ago
Santhera Pharmaceuticals Reports Strong H1 2025 Growth
Premium
Company Announcements
Santhera Pharmaceuticals Reports Strong H1 2025 Growth
7M ago
Santhera Pharmaceuticals: Buy Rating Affirmed on Strong Commercial Traction and Promising Financial Outlook
Premium
Ratings
Santhera Pharmaceuticals: Buy Rating Affirmed on Strong Commercial Traction and Promising Financial Outlook
11M ago
Santhera Pharmaceuticals: Transformative Year with AGAMREE Success
Premium
Company Announcements
Santhera Pharmaceuticals: Transformative Year with AGAMREE Success
11M ago
Santhera Pharmaceuticals: Buy Rating Affirmed on Strategic Milestones and Growth Prospects
Premium
Ratings
Santhera Pharmaceuticals: Buy Rating Affirmed on Strategic Milestones and Growth Prospects
1y ago
More CH:SANN News >

SANN News on the Web

Santhera: Advancing AGAMREE Reimbursement and European Uptake Underpins Reiterated Buy and CHF30 Target
TipRanks News
Bullish
Santhera Pharma Appoints Marc Clausse As Chief Commercial Officer
rttnews
Bullish
Swissmedic Approves Santhera's AGAMREE For Duchenne Muscular Dystrophy
rttnews
Bullish
Santhera Pharmaceuticals Reports Strong H1 2025 Growth
TipRanks News
Neutral
Week In Review: AriBio Sells China Rights To Alzheimer’s Candidate In $770 Million Deal
TalkMarkets
Neutral
Analysts Offer Insights on Healthcare Companies: Santhera Pharmaceuticals Holding (OtherSPHDF), Ironwood Pharma (IRWD) and Cytokinetics (CYTK)
TipRanks News
Neutral
3 Unstoppable S&P 600 Small-Cap Stocks to Buy in January
InvestorPlace
Neutral
Analysts Conflicted on These Healthcare Names: Amylyx Pharmaceuticals Inc (AMLX), Santhera Pharmaceuticals Holding (OtherSPHDD) and Alkermes (ALKS)
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
CH:SANN
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CH:SANN’s Media Buzz Sentiment?
1 articles about CH:SANN were published this week. In an average week, 1 articles are published.
    What is CH:SANN’s weekly average amount of articles?
    In an average week, 1 articles about CH:SANN are published.
      What is CH:SANN’s News Sentiment?
      100% of articles about CH:SANN were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        NBIXNeurocrine
        STAAStaar Surgical
        AORTArtivion
        OWLTOwlet
        HUMHumana
        Showing the stocks with the most bullish news sentiment over the past week